Clinical Trials Related to Phentolamine Ophthalmic Solution 0.75%

Related studies linked through entity extraction aliases.

Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects

Status: COMPLETED
Phase: PHASE3

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)

Status: COMPLETED
Phase: PHASE3

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Status: COMPLETED
Phase: PHASE3

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Status: COMPLETED
Phase: PHASE3